CD274 and neoplasm: Analysis of only TMIT II and III cases (CD8low and either PD-L1pos or PD-L1neg) revealed a worse overall survival for those tumours expressing PD-L1, although not statistically significant (LR 3.593, p = 0.058) (Figure 3).